Myoungki Baek
CDO,
TRIOAR Inc.
Pharmaceutical R&D executive with extensive experience leading translational research, IND-enabling studies, and early clinical development. Successfully advanced multiple drug candidates to IND approval and licensing deals, with expertise spanning oncology, CNS, and metabolic diseases.
Sessions
-
18-Jun-2025153ATRIOAR
)
)
){kind=logo}
){kind=logo}
){kind=logo}